Cleared Traditional

K050662 - QUANTA LITE SP100 ELISA (FDA 510(k) Clearance)

Jun 2005
Decision
90d
Days
Class 2
Risk

K050662 is an FDA 510(k) clearance for the QUANTA LITE SP100 ELISA. This device is classified as a Autoantibodies, Nuclear Body Protein, Sp100 (Class II - Special Controls, product code NUM).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on June 13, 2005, 90 days after receiving the submission on March 15, 2005.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5090. The Device Is Used For The Detection, In Human Serum Or Plasma, Of Autoantibodies To Sp100 (nuclear Body Protein Sp100) As An Aid In The Diagnosis Of Primary Biliary Cirrhosis..

Submission Details

510(k) Number K050662 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2005
Decision Date June 13, 2005
Days to Decision 90 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code NUM — Autoantibodies, Nuclear Body Protein, Sp100
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5090
Definition The Device Is Used For The Detection, In Human Serum Or Plasma, Of Autoantibodies To Sp100 (nuclear Body Protein Sp100) As An Aid In The Diagnosis Of Primary Biliary Cirrhosis.